Jeffrey Skolnik, MD on How INO-5401 Makes a Difference for Patients with GBM #ASCO2020 #ASCO @InovioPharma

Jeffrey Skolnik, MD on How INO-5401 Makes a Difference for Patients with GBM #ASCO2020 #ASCO @InovioPharma

User Photo
Cancer-News

3 months
18 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Jeffrey Skolnik, MD of INOVIO Pharmaceuticals @InovioPharma discusses INO-5401 in combination with PD-1 inhibitor libtayo (cemiplimab) demonstrates 85%of newly diagnosed glioblastoma patients are alive12 months following treatment.

Read here: http://s23.q4cdn.com/479936946/files/doc_news/INOVIOs-INO-5401-in-Combination-with-PD-1-Inhibitor-Libtayo-cemiplimab-Demonstrates-85-of-Newly-Diagnosed-Glioblastoma-Patients-Are-A-5VT78.pdf

Up Next Autoplay